[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343074-105":59,"doc-detail-343074-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nad-metabolism-enzyme-nnmt-in-cancer-associated-fibroblasts-drives-tumor-progression-and-resistance-to-immunotherapy-by-modulating-macrophages-in-urothelial-bladder-cancer-original-research","NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer - Original research","","This open-access original research investigates how nicotinamide N-methyltransferase (NNMT), a NAD+ metabolism enzyme, relates to clinical outcomes in urothelial bladder cancer and explains molecular mechanisms in cancer-associated fibroblasts (CAFs). Using single-cell transcriptomics plus immunohistochemistry/immunofluorescence, the study validates links between NNMT expression and patient outcomes. Mechanistic work combines chromatin immunoprecipitation, LC-MS/MS, and CRISPR-Cas9 in vivo models. Elevated NNMT+ CAFs associates with PD-L1 blockade non-response and poor prognosis, and NNMT inhibition reduces tumor growth and augments apoptosis effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nad-metabolism-enzyme-nnmt-in-cancer-associated-fibroblasts-drives-tumor-progression-and-resistance-to-immunotherapy-by-modulating-macrophages-in-urothelial-bladder-cancer-original-research/343074/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nad-metabolism-enzyme-nnmt-in-cancer-associated-fibroblasts-drives-tumor-progression-and-resistance-to-immunotherapy-by-modulating-macrophages-in-urothelial-bladder-cancer-original-research/343074.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study in urothelial bladder cancer?","Question",{"text":112,"@type":113},"The study examines the relationship between NNMT expression in cancer-associated fibroblasts and clinical outcomes, and it explores how NNMT drives tumor progression and resistance to PD-L1 blockade immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the authors validate NNMT’s clinical and biological relevance?",{"text":117,"@type":113},"They use single-cell transcriptomic analyses and immunohistochemical/immunofluorescence assays on bladder cancer samples, supported by mechanistic experiments including chromatin immunoprecipitation, LC-MS/MS, and CRISPR-Cas9 knockout within vivo models.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism do NNMT+ CAFs use to confer immunotherapy resistance?",{"text":121,"@type":113},"The study reports that NNMT+ CAFs recruit tumor-associated macrophages through epigenetic reprogramming involving serum amyloid A (SAA), promoting tumor proliferation and resistance to PD-1/PD-L1 blockade therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343074,1790176383,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Open access  \nTo cite: Yang M, Wang B, Hou W, et al. NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. Journal for ImmunoTherapy of Cancer 2024;12:e009281 . doi:10 . 1136/ jitc-2024-009281  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2024-009281](jitc-2024-009281)) .  \nMY, BW and WH contributed equally.  \nMY, BW and WH are joint first authors.  \nAccepted 21 June 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Jian Huang;  \n[huangj8@mail.sysu.edu.cn](huangj8@mail.sysu.edu.cn)  \nTianxin Lin;  \n[lintx@mail.sysu.edu.cn](lintx@mail.sysu.edu.cn)  \nProfessor Haide Qin; [qinhd3@mail.sysu.edu.cn](qinhd3@mail.sysu.edu.cn)  \nOriginal research  \nNAD + metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial  \nbladder cancer  \nMeihua Yang  ,1,2,3 Bo Wang  ,1,2 Weibin Hou,1,4 Honghui Zeng,2,3 Wang He,1,2 Xin-Ke Zhang,5 Dong Yan,1,2 Hao Yu  ,1,2 Long Huang,2 Lu Pei,6 Kaiwen Li,1,2 Haide Qin,2 Tianxin Lin,1,2 Jian Huang  1,2  \nABSTRACT  \nBackground This study comprehensively investigates the association between the expression of nicotinamide N-methyltransferase (NNMT) and clinical outcomes of urothelial bladder cancer (UBC), as well as the molecular mechanisms by which NNMT in cancer-associated fibroblast (CAF) modulates tumor progression and immunotherapy resistance in UBC.  \nMethods Single-cell transcriptomic analyses, immunohistochemical and immunofluorescence assays were performed on bladder cancer samples to validate the relationship between NNMT expression and clinical outcomes. A series of experiments, including chromatin immunoprecipitation assay, liquid chromatography tandem mass spectrometry assay, and CRISPR‒Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9) knockout, together within vivo models, have been established to determine the molecular functions of NNMT in CAFs in UBC.  \nResults We demonstrated that elevated expression of the nicotinamide adenine dinucleotide (NAD+) metabolism enzyme NNMT in CAFs (NNMT+ CAFs) was significantly associated with non-response to programmed deathligand 1 (PD-L1) blockade immunotherapy in patients with UBC and predicted the unfavorable prognosis of UBC in two independent large cohorts. Targeting NNMT using the inhibitor 5-Amino-1-methylquinolinium iodide significantly reduced tumor growth and enhanced theapoptotic effects of the anti-PD-L1 antibody in UBC mouse models. Mechanistically, NNMT+ CAFs recruit tumorassociated macrophages via epigenetic reprogramming of serum amyloid A (SAA) to drive tumor cell proliferation and confer resistance to programmed death-1/PD-L1 blockade immunotherapy.  \nConclusions NNMT+ CAFs were significantly associated with non-response to PD-L1 blockade immunotherapy in patients with UBC. Elevated NNMT, specifically in CAFs, upregulates SAA expression and enhances the recruitment and differentiation of macrophages in the tumor microenvironment, thereby directly or indirectly  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Although robust and durable responses have been obtained by immune checkpoint inhibitors (ICIs) immunotherapy for urothelial bladder cancer (UBC), only a small subset of patients could benefit from ICI-based immunotherapy. Therefore, elucidating the determinants conferring resistance to immunotherapy is crucial and urgently needed.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ Nicotinamide N-methyltransferase (NNMT+) cancerassociated fibroblasts (CAFs) are significantly associated with ","cbCailJFLZXlo0VK","https://ap.wps.com/l/cbCailJFLZXlo0VK","pdf",15013718,23,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Introduction","[{\"question\":\"What is the main focus of the study in urothelial bladder cancer?\",\"answer\":\"The study examines the relationship between NNMT expression in cancer-associated fibroblasts and clinical outcomes, and it explores how NNMT drives tumor progression and resistance to PD-L1 blockade immunotherapy.\"},{\"question\":\"How do the authors validate NNMT’s clinical and biological relevance?\",\"answer\":\"They use single-cell transcriptomic analyses and immunohistochemical/immunofluorescence assays on bladder cancer samples, supported by mechanistic experiments including chromatin immunoprecipitation, LC-MS/MS, and CRISPR-Cas9 knockout within vivo models.\"},{\"question\":\"What mechanism do NNMT+ CAFs use to confer immunotherapy resistance?\",\"answer\":\"The study reports that NNMT+ CAFs recruit tumor-associated macrophages through epigenetic reprogramming involving serum amyloid A (SAA), promoting tumor proliferation and resistance to PD-1/PD-L1 blockade therapy.\"}]","NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer - Original research | PDF",1790049773,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd905ec85d64af02f9e14cbc76752f58.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edd069bd1e96be3564669091c42c369e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e6f6ebea4cc36e382ded0a9eae2de8f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a3a5ef24aca9d50dc6bc187d1040850.webp",980,1306]